5 Results for "

Tumor targeted pro-apoptotic peptide

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Tumor targeted pro-apoptotic peptide" in MCE Product Catalog:

Cat. No.: HY-P3707
CAS No.: 1926163-30-5
Target:  

Apoptosis

Research Areas:  

Cancer

Tumor targeted pro-apoptotic peptide (CNGRC-GG-D(KLAKLAK)2) is an anti-tumor peptide. Tumor targeted pro-apoptotic peptide disrupts mitochondrial membranes and promotes apoptosis, showing anticancer activity in mice .
loading...
    loading...
Cat. No.: HY-P4091
CAS No.: 945245-76-1
Research Areas:  

Cancer

LSD is a peptide. LSD can specifically recognize the lymphatics of C8161 melanoma, but it does not bind to the lymphatics of normal tissues or tumor blood vessels. When conjugated with a proapoptotic peptide, LSD can reduce the number of tumor lymphatics. LSD can be used in the research of targeted therapy and diagnosis of tumor lymphatics .
loading...
    loading...
Cat. No.: HY-P4903
CAS No.: 2243207-09-0
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

RGD-targeted Proapoptotic Peptide is a peptide. The C-terminal RGD-4C peptide (ACDCRGDCFC) binds preferentially to integrins at sites of tumor angiogenesis.
loading...
    loading...
Cat. No.: HY-P10786
CAS No.: 2031154-77-3
Research Areas:  

Cancer

LinTT1 peptide is a tumor-penetrating peptide with the amino acid sequence AKRGARST. LinTT1 peptide targets peritoneal carcinoma (PC) by binding to the p32 (gC1qR) receptor. It can conjugate with iron oxide nanoworms (NWs) to form a nanocarrier. This nanocarrier is taken up by peritoneal carcinoma cells in vitro and enters the mitochondria; it also exhibits significant tumor targeting and penetration effects in mice. Moreover, LinTT1-functionalized nanocarriers, combined with the pro-apoptotic peptide [D(KLAKLAK)2], show significant tumor suppression in a mouse peritoneal tumor model. LinTT1 peptide holds promise as a delivery carrier for peritoneal cancer research .
loading...
    loading...
Cat. No.: HY-P4091A
Research Areas:  

Cancer

LSD acetate is a peptide. LSD acetate can specifically recognize the lymphatics of C8161 melanoma, but it does not bind to the lymphatics of normal tissues or tumor blood vessels. When conjugated with a proapoptotic peptide, LSD acetate can reduce the number of tumor lymphatics. LSD acetate can be used in the research of targeted therapy and diagnosis of tumor lymphatics .
loading...
    loading...